• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

桥粒斑蛋白心肌病,一种与典型扩张型或致心律失常性右室心肌病不同的纤维性和炎症性心肌病。

Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy.

机构信息

Department of Internal Medicine, Division of Cardiovascular Medicine (E.D.S., P.A., A.S.H.), University of Michigan, Ann Arbor.

Cardiovascular Genetics Program, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (N.K.L., K.N.).

出版信息

Circulation. 2020 Jun 9;141(23):1872-1884. doi: 10.1161/CIRCULATIONAHA.119.044934. Epub 2020 May 6.

DOI:10.1161/CIRCULATIONAHA.119.044934
PMID:32372669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7286080/
Abstract

BACKGROUND

Mutations in desmoplakin (), the primary force transducer between cardiac desmosomes and intermediate filaments, cause an arrhythmogenic form of cardiomyopathy that has been variably associated with arrhythmogenic right ventricular cardiomyopathy. Clinical correlates of cardiomyopathy have been limited to small case series.

METHODS

Clinical and genetic data were collected on 107 patients with pathogenic mutations and 81 patients with pathogenic plakophilin 2 () mutations as a comparison cohort. A composite outcome of severe ventricular arrhythmia was assessed.

RESULTS

and cohorts included similar proportions of probands (41% versus 42%) and patients with truncating mutations (98% versus 100%). Left ventricular (LV) predominant cardiomyopathy was exclusively present among patients with (55% versus 0% for , <0.001), whereas right ventricular cardiomyopathy was present in only 14% of patients with versus 40% for (<0.001). Arrhythmogenic right ventricular cardiomyopathy diagnostic criteria had poor sensitivity for cardiomyopathy. LV late gadolinium enhancement was present in a primarily subepicardial distribution in 40% of patients with (23/57 with magnetic resonance images). LV late gadolinium enhancement occurred with normal LV systolic function in 35% (8/23) of patients with . Episodes of acute myocardial injury (chest pain with troponin elevation and normal coronary angiography) occurred in 15% of patients with and were strongly associated with LV late gadolinium enhancement (90%), even in cases of acute myocardial injury with normal ventricular function (4/5, 80% with late gadolinium enhancement). In 4 cases with 18F-fluorodeoxyglucose positron emission tomography scans, acute LV myocardial injury was associated with myocardial inflammation misdiagnosed initially as cardiac sarcoidosis or myocarditis. Left ventricle ejection fraction <55% was strongly associated with severe ventricular arrhythmias for cases (<0.001, sensitivity 85%, specificity 53%). Right ventricular ejection fraction <45% was associated with severe arrhythmias for cases (<0.001) but was poorly associated for cases (=0.8). Frequent premature ventricular contractions were common among patients with severe arrhythmias for both (80%) and (91%) groups (=non-significant).

CONCLUSIONS

cardiomyopathy is a distinct form of arrhythmogenic cardiomyopathy characterized by episodic myocardial injury, left ventricular fibrosis that precedes systolic dysfunction, and a high incidence of ventricular arrhythmias. A genotype-specific approach for diagnosis and risk stratification should be used.

摘要

背景

桥粒芯蛋白()中的突变是心脏桥粒与中间丝之间的主要力传感器,可导致心律失常形式的心肌病,该心肌病与致心律失常性右室心肌病(arrhythmogenic right ventricular cardiomyopathy,ARVC)有不同程度的关联。对 心肌病的临床相关性的研究仅限于小的病例系列。

方法

对 107 例携带致病性 突变和 81 例携带致病性桥粒斑蛋白 2()突变的患者(作为比较队列)进行临床和遗传数据收集。评估严重室性心律失常的复合结局。

结果

和 两组的先证者比例(41%对 42%)和截断突变患者比例(98%对 100%)相似。左心室(left ventricular,LV)为主型心肌病仅存在于 患者中(55%对 患者为 0%,<0.001),而右心室心肌病仅存在于 患者的 14%(40%)<0.001)。致心律失常性右室心肌病的诊断标准对 心肌病的敏感性较差。LV 晚期钆增强在 40%的 患者中呈主要心外膜分布(有磁共振成像的 57 例患者中有 23 例)。LV 晚期钆增强在 35%(23 例中的 8 例)的 患者中发生在 LV 收缩功能正常的情况下。15%的 患者发生急性心肌损伤(胸痛伴肌钙蛋白升高和正常冠状动脉造影),与 LV 晚期钆增强强烈相关(90%),甚至在急性心肌损伤合并正常心室功能的情况下(4/5,80%有晚期钆增强)也是如此。在 4 例接受 18F-氟脱氧葡萄糖正电子发射断层扫描(fluorodeoxyglucose positron emission tomography,FDG-PET)扫描的患者中,急性 LV 心肌损伤与最初误诊为心脏结节病或心肌炎的心肌炎症相关。对于 病例,左心室射血分数(left ventricular ejection fraction,LVEF)<55%与严重室性心律失常强烈相关(<0.001,敏感性 85%,特异性 53%)。对于 病例,右心室射血分数(right ventricular ejection fraction,RVEF)<45%与严重心律失常相关(<0.001),但与 病例相关性差(=0.8)。对于严重心律失常的患者,频发室性早搏在 和 两组中均很常见(分别为 80%和 91%,=非显著)。

结论

心肌病是一种心律失常性心肌病的独特形式,其特征为间歇性心肌损伤、左心室纤维化先于收缩功能障碍以及室性心律失常发生率高。应采用基于基因类型的诊断和风险分层方法。

相似文献

1
Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy.桥粒斑蛋白心肌病,一种与典型扩张型或致心律失常性右室心肌病不同的纤维性和炎症性心肌病。
Circulation. 2020 Jun 9;141(23):1872-1884. doi: 10.1161/CIRCULATIONAHA.119.044934. Epub 2020 May 6.
2
DSP p.(Thr2104Glnfs*12) variant presents variably with early onset severe arrhythmias and left ventricular cardiomyopathy.DSP 基因 p.(Thr2104Glnfs*12) 变异体表现为早发严重心律失常和左心室心肌病,其临床表现具有多样性。
BMC Med Genet. 2020 Jan 31;21(1):19. doi: 10.1186/s12881-020-0955-z.
3
Left-dominant arrhythmogenic cardiomyopathy due to desmoplakin mutation: a case report.致心律失常性右室心肌病伴左室心肌病变:一例报道。
ESC Heart Fail. 2023 Oct;10(5):3190-3194. doi: 10.1002/ehf2.14504. Epub 2023 Aug 26.
4
Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation.致心律失常性右室心肌病的桥粒斑蛋白错义和非错义突变:基因型-表型相关性。
Int J Cardiol. 2017 Dec 15;249:268-273. doi: 10.1016/j.ijcard.2017.05.018. Epub 2017 May 10.
5
A case series of desmoplakin cardiomyopathy: a mimic of viral myocarditis.桥粒斑蛋白心肌病病例系列:一种酷似病毒性心肌炎的疾病
Eur Heart J Case Rep. 2022 Aug 16;6(8):ytac341. doi: 10.1093/ehjcr/ytac341. eCollection 2022 Aug.
6
Clinical characteristics and risk stratification of desmoplakin cardiomyopathy.桥粒芯糖蛋白心肌病的临床特征和危险分层。
Europace. 2022 Feb 2;24(2):268-277. doi: 10.1093/europace/euab183.
7
Clinical profile and long-term follow-up of a cohort of patients with desmoplakin cardiomyopathy.特发性心肌致密化不全的临床特征和长期随访结果。
Heart Rhythm. 2022 Aug;19(8):1315-1324. doi: 10.1016/j.hrthm.2022.04.015. Epub 2022 Apr 22.
8
Desmoplakin truncations and arrhythmogenic left ventricular cardiomyopathy: characterizing a phenotype.桥粒斑蛋白截短与致心律失常性左室心肌病:一种表型特征描述
Europace. 2014 Dec;16(12):1838-46. doi: 10.1093/europace/euu128. Epub 2014 Jun 17.
9
Familial Recurrent Myocarditis Triggered by Exercise in Patients With a Truncating Variant of the Desmoplakin Gene.家族性复发性心肌炎由 Desmoplakin 基因突变截断型引起,发病与运动相关。
J Am Heart Assoc. 2020 May 18;9(10):e015289. doi: 10.1161/JAHA.119.015289. Epub 2020 May 15.
10
Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy.桥粒斑蛋白的新型突变导致致心律失常性左室心肌病。
Circulation. 2005 Aug 2;112(5):636-42. doi: 10.1161/CIRCULATIONAHA.104.532234.

引用本文的文献

1
Creating an atlas of variant effects to resolve variants of uncertain significance and guide cardiovascular medicine.创建一个变异效应图谱,以解析意义未明的变异并指导心血管医学。
Nat Rev Cardiol. 2025 Sep 1. doi: 10.1038/s41569-025-01201-7.
2
Advancements and challenges in pediatric dilated cardiomyopathy: a comprehensive review of current approaches and future directions.小儿扩张型心肌病的进展与挑战:当前方法及未来方向的全面综述
Eur J Pediatr. 2025 Aug 12;184(9):546. doi: 10.1007/s00431-025-06263-w.
3
Left Ventricular Ring-like Pattern: The Arrhythmic Tale of a Scarred Heart.

本文引用的文献

1
Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis.致心律失常性右室心肌病:当前诊断标准及鉴别诊断的评估
Eur Heart J. 2020 Apr 7;41(14):1414-1429. doi: 10.1093/eurheartj/ehz669.
2
Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy.心律失常性心肌病免疫反应的治疗调节。
Circulation. 2019 Oct 29;140(18):1491-1505. doi: 10.1161/CIRCULATIONAHA.119.040676. Epub 2019 Sep 19.
3
Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy.
左心室环状模式:一颗伤痕累累心脏的心律失常故事。
J Cardiovasc Dev Dis. 2025 Jul 17;12(7):275. doi: 10.3390/jcdd12070275.
4
A case of arrhythmic cardiomyopathy caused by rare multiple gene mutations.一例由罕见的多个基因突变引起的心律失常性心肌病。
Front Cardiovasc Med. 2025 Jul 10;12:1598085. doi: 10.3389/fcvm.2025.1598085. eCollection 2025.
5
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric Study.纽蛋白(NEXN)相关心肌病的遗传学和表型特征:一项多中心研究的结果
JACC Heart Fail. 2025 Sep;13(9):102529. doi: 10.1016/j.jchf.2025.102529. Epub 2025 Jul 18.
6
Diagnostic Criteria and Disease Staging for Desmoplakin Cardiomyopathy.桥粒斑蛋白心肌病的诊断标准和疾病分期
medRxiv. 2025 Jun 23:2025.06.16.25329734. doi: 10.1101/2025.06.16.25329734.
7
Cardiac Myocyte Cytosolic Self-DNA Contributes to the Pathogenesis of Desmoplakin-Cardiomyopathy.心肌细胞胞质中的自身DNA促成桥粒斑蛋白心肌病的发病机制。
JCI Insight. 2025 Jul 3. doi: 10.1172/jci.insight.192283.
8
Tailored therapeutics for cardiomyopathies.针对心肌病的个性化疗法。
Nat Rev Cardiol. 2025 Jun 27. doi: 10.1038/s41569-025-01183-6.
9
Cause-Specific Mortality in Patients Hospitalized for Myocarditis from 2004 to 2021: A Retrospective Statewide Population-Linkage Study.2004年至2021年因心肌炎住院患者的特定病因死亡率:一项全州范围的回顾性人群关联研究
J Clin Med. 2025 Jun 10;14(12):4089. doi: 10.3390/jcm14124089.
10
Broad Electrocardiogram Syndromes Spectrum: From Common Emergencies to Particular Electrical Heart Disorders-Part II.广义心电图综合征谱:从常见急症到特殊心脏电疾病 - 第二部分
Diagnostics (Basel). 2025 Jun 19;15(12):1568. doi: 10.3390/diagnostics15121568.
扩张型心肌病患者心律失常表型的遗传风险。
J Am Coll Cardiol. 2019 Sep 17;74(11):1480-1490. doi: 10.1016/j.jacc.2019.06.072.
4
Exercise restores dysregulated gene expression in a mouse model of arrhythmogenic cardiomyopathy.运动可恢复致心律失常性心肌病小鼠模型中失调的基因表达。
Cardiovasc Res. 2020 May 1;116(6):1199-1213. doi: 10.1093/cvr/cvz199.
5
Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study.扩张型心肌病和致心律失常性左室心肌病:一项综合的基因型-影像表型研究。
Eur Heart J Cardiovasc Imaging. 2020 Mar 1;21(3):326-336. doi: 10.1093/ehjci/jez188.
6
Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies.遗传性心肌病致危及生命性室性心律失常新型风险预测评分的建立与验证。
Circulation. 2019 Jul 23;140(4):293-302. doi: 10.1161/CIRCULATIONAHA.118.039410. Epub 2019 Jun 3.
7
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy.2019 HRS 专家共识声明:心律失常性心肌病的评估、风险分层和管理。
Heart Rhythm. 2019 Nov;16(11):e301-e372. doi: 10.1016/j.hrthm.2019.05.007. Epub 2019 May 9.
8
A novel genotype-based clinicopathology classification of arrhythmogenic cardiomyopathy provides novel insights into disease progression.一种基于新型基因型的心律失常性心肌病临床病理分类为疾病进展提供了新的见解。
Eur Heart J. 2019 Jun 1;40(21):1690-1703. doi: 10.1093/eurheartj/ehz172.
9
A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.致心律失常性右室心肌病室性心律失常的新预测模型。
Eur Heart J. 2019 Jun 14;40(23):1850-1858. doi: 10.1093/eurheartj/ehz103.
10
Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy.RBM20 区域变异导致高度外显的心律失常性心肌病。
Circ Heart Fail. 2019 Mar;12(3):e005371. doi: 10.1161/CIRCHEARTFAILURE.118.005371.